Figure 1. Clinical importance of AQP5 in non small cell lung cancer. (A) Immunohistochemistry of AQP5.
Photomicrographs of AQP5 immunostaining in arrayed non small cell lung cancer (NSCLC) tissues. Examples of weak (+1), moderate (+2), and strong (+3) immunoreactivity in NSCLCs (a to c, respectively) Original magnification Ć200. (B) Kaplan Meier Curve in NSCLC patients. AQP5-positive cases displayed a less favorable disease-free survival rate (log rank pā=ā0.011) than AQP5-negative cases.
